|
|
||||||||
|
|
|||||||||
|
|
General Clinical Specialties: General Practice-OncologyGeneral Practice-Oncology Posters |
1 Department of Nuclear Medicine; 2 Department of Radiology, Tri-Service General Hospital, Taipei, Taiwan; 3 Department of Nuclear Medicine, William Beaumont Hospital, Royal Oak, Michigan
1114
Objectives: To evaluate the incremental diagnostic value of integrated interpretation of PET/CT in evaluating solitary pulmonary nodules for malignancy.
Methods: A total of 117 patients (67 male and 50 female, mean age±SD: 61.7±13.6 years, range: 31-86 years) with indeterminate SPN and without previous history of malignancy were analyzed. The PET/CT was performed 1 hr after a 370 MBq 18F-FDG intravenous injection using an integrated PET/CT scanner (Siemens Biograph BGO duo). Patients fasted 6 hr prior the imaging. PET was interpreted alone or combined with CT and was graded with the five-point scale (J Nucl Med 2007;48: 214). Malignant diagnosis was based on histological findings, or a clinical and radiological follow-up of at least 15 months. Diagnostic performance of PET alone and PET/CT were performed using a discriminate analysis (SPSS Inc, Chicago, IL).
Results: PET alone classified correctly 86% and the integrated criteria increased the correct classification to 89% yet comparable sensitivity and specificity of 88% and 89% respectively. Eight PET equivocal cases by PET alone were resolved (>50%) cases when combined with CT interpretation.
Conclusions: While additional gain of integrated PET/CT from the non-contrast CT was limited, PET and CT are synergistic and significantly increment of diagnostic value in PET equivocal cases.
| ||||||||||||||||||||||||||||||||||||||